|
|
Conference:
Pre-conference workshop
1 Dec 9am - 5pm
Day 1
2 Dec 8.30am - 5:30pm
Day 2
3 Dec 8.30am - 5:30pm
Post-conference workshop
4 Dec 8.30am - 5:30pm
Venue:
The Bloomsbury Hotel, London, United Kingdom
› Email a friend
› Add this to my calendar
|
|
|
The 'must attend' late phase drug development conference
|
For delegates
Late phase drug development is growing at around 20% annually, exceeding the growth rate of Phase II and III Trials. In excess of $12 billion is currently being spent on Phase IIIb/IV studies as public concerns on the safety of approved drugs prevail together with the need to evaluate real world safety and effectiveness of marketed drugs. More than ever before there is the urgent need to detect, quantify and communicate patient risk with speed and efficiency.
As a result, Health Network Communications is delighted to announce the first ever strategic forum addressing the major challenges in conducting strategic and compliant late stage studies.
» Download final brochure
|
|
Keynote speaker - Strategic Challenges of Late Stage Development
|
Dr Ellen Strahlman, Senior Vice President & Chief Medical Officer, GlaxoSmithKline
|
|
|
Our speakers
Our eminent speaker panel will include thought leaders and practitioners in late phase trials from the industry, academia and contract services. At Late Phase Drug Development World you can expect to see speakers from a wide range of countries. There will be case study updates, and we will introduce fresh strategy content as we continue to keep track of the latest developments.
|
For sponsors
Position and profile yourself as an industry leader at the most prestigious meeting place of the year. As a sponsor of this event you will be able to consider the most appropriate way to present your products and services and select a sponsorship package that is best suited to your marketing objectives.
» Find out how you could benefit
|
Why should you sponsor this event?
Late Phase Drug Development World aims to attract the biggest gathering of pharmaceutical late phase drug development thought leaders to assemble in 2009. How are you going to make sure you stand out from the crowd? Invest in the event, your company’s future; and make sure your clients know who you are.
The event will attract Directors and Managers of Clinical trials, Clinical research, Post marketing, Surveillance, Medical Affairs, Pharmacoepidemiology, Investigator sponsored studies, Clinical Data, Management, Drug development, Pharmacovigilance, Risk Management from the pharmaceutical and biotechnology industries.
- Learn from top level speakers
- Uncover new opportunities and generate leads
- Gain access to your target market
- Integrate with the pharma marketing community
- Enhance your brand and market position
- Showcase your products and services
» Find out more
» Looking for an event taking place sooner or in a different part of the world?
|
|
|
|
Dr Ellen Strahlman
Chief Medical Officer
GlaxoSmithKline
Dr Clive Morris
Medical Science Director
AstraZeneca
Mark Latymer
Scientific Advisor
Pfizer
Amy Sing
Associate Group Director - Post Marketing
Genentech
Professor Markus Kosch
Associate Medical Director
Wyeth Pharma
|
|
|
|
|
|
|
|
|
